enasidenib,azacitidine
bms,servier
['leukemia', 'myeloid', 'enasidenib', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders),(-dreamlike)', 'azacitidine,(-oral azaci),(-azacitidine oral)', 'leusm']
#ash22: sheng cai will present data from a three-year follow-up of enasidenib + subsequent response-driven addition of azacitidine for newly diagnosed idh2-mutant #acutemyeloidleukemia patients. monday at 4:00 p.m. #leusm #amlsm learn more: 
The official account of @MSKCancerCenter’s Department of Medicine. Chair/Dept head @debschrag